查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466346

體外膜氧合裝置市場：按模式、年齡、組件、應用和最終用戶 - 2024-2030 年全球預測

Extracorporeal Membrane Oxygenation Machine Market by Modality (Arteriovenous ECMO, Venoarterial ECMO, Venovenous ECMO), Age (Adult, Neonate, Pediatric), Component, Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

體外膜氧合裝置市場規模預估2023年為7.9486億美元，2024年達8.3214億美元，預估2030年將達10.8563億美元，複合年成長率為4.55%。

體外膜氧合是醫療設備為心臟和肺部無法交換足夠氣體維持生命的患者提供長期的心臟和呼吸支持。這些機器從患者體內抽取血液，使其通過氧合器（膜），提供氧氣並去除二氧化碳，然後將其返回患者的血液中。這種外部生命維持系統接管心臟和肺部的功能，使這些器官在嚴重疾病期間得到休息和恢復。心血管和呼吸系統疾病的迅速增加以及改善患者治療效果的技術進步導致 ECMO 系統的採用越來越多。此外，醫療基礎設施的改善和醫療費用的上漲也促進了市場的擴張。 ECMO 程序相關的高成本以及接受過操作這些機器培訓的醫療專業人員數量有限，為市場成長帶來了挑戰。也就是說，ECMO 設備設計的進步提高了各種治療環境中的攜帶性和易用性，預計將為市場提供機會。此外，ECMO 與其他體外療法相結合，專注於擴大 ECMO 支持適應症的研究活動預計將推動市場發展。

主要市場統計
基準年[2023] 7.9486億美元
預測年份 [2024] 8.3214億美元
預測年份 [2030] 10.8563 億美元
複合年成長率（%） 4.55%

增加使用靜脈-動脈 ECMO 來支持心臟和呼吸系統

動靜脈體外膜氧氣療法(AV ECMO) 是一種較舊的 ECMO 支持方法，它利用患者的動脈和靜脈血流驅動 ECMO 迴路內的血液。在 AV ECMO 中，血液從動脈抽出，氧合後回到靜脈。該過程依賴患者的心臟透過氧合器泵血。近年來，隨著技術進步在效率和安全性方面有利於其他治療方式，ECMO 治療已變得不那麼常見。靜脈動脈體外膜氧合 (VA ECMO) 透過抽取靜脈血並將在體外氧合的血液重新註入動脈，支持心臟和呼吸。 VA ECMO 用於治療嚴重心臟衰竭或心臟麻痹的情況，因為它繞過心臟和肺部，為這些器官提供完整的支持。插管通常透過大的中央靜脈進行，例如股動脈或頸動脈。 VA ECMO 主要用於呼吸支持；血液從大靜脈中取出，透過 ECMO 迴路充氧，然後返回靜脈。當肺部因急性呼吸窘迫症候群(ARDS) 或肺炎等情況嚴重受損時，此 ECMO 模式可確保足夠的氧氣供應。 VV ECMO 的典型插管部位是頸內靜脈和股靜脈。

年齡：由於呼吸系統疾病和心臟病，對成人 ECMO 設備的需求增加

需要 ECMO 治療的成年患者患有嚴重的呼吸系統或心臟疾病，對常規治療沒有反應。這包括急性呼吸窘迫症候群(ARDS)、心源性休克和肺動脈栓塞等疾病。成人 ECMO 設備旨在透過可承受長期使用的耐用組件來管理更大的血流量。由於先天性疝氣或湄公河誤吸症候群等出生時的情況，新生兒需要 ECMO 支持。新生兒 ECMO 設備旨在透過精確控制和溫和的流量來處理新生兒微妙和最小的血量，最大限度地減少溶血和其他血液相關併發症的風險。新生兒 ECMO 設備的主要特點是注重減少侵入性並根據患者體型限制體外迴路的數量。新生兒 ECMO 設備比用於年齡較大的兒童和成人的設備具有較小的插管和專門的電路。兒童患者，從嬰幼兒到年齡較大的兒童，可能需要 ECMO 來治療對標準治療無反應的各種呼吸和心臟衰竭病症。兒童用ECMO 設備必須具有多功能性，可調節流量和氧合器尺寸，以適應該群體中不同年齡和體型的患者。

組件：ECMO 設備對耐用且生物相容性氧合器的需求不斷增加

抗凝血系統對於 ECMO 設定至關重要，可防止血液通過 ECMO 迴路並流出體外時發生凝結。 ECMO機器中的混合器將空氣和純氧混合，控制氧氣濃度並將其輸送給患者。混合器必須能夠調節氧氣濃度範圍以滿足不同患者的需求。插管是病患與 ECMO 設備之間的血流導管，有多種尺寸和材質可供選擇，以滿足特定病患的解剖結構和手術要求。熱交換器對於 ECMO 治療期間調節血液溫度和維持患者體溫非常重要。監測系統對於監測患者生命徵象和 ECMO 機器性能非常重要。氧合器是 ECMO 機器的心臟，在這裡進行氣體交換。製造商現在生產的氧合器可以最大限度地提高氣體交換效率，同時最大限度地減少血液創傷。幫浦透過 ECMO 迴路泵送血液，離心式幫浦和滾子泵是 ECMO 機器中的兩種主要泵。離心式幫浦因其低溶血率而受到青睞，滾子泵因其簡單性和成本效益而受到青睞。

用途體外心肺復甦術 (ECPR) 擴大用於快速恢復重要器官的氧血流。

ECMO 設備廣泛用於心臟應用，作為嚴重心臟衰竭患者和高風險心血管手術期間生命支持的橋樑。以這種方式使用時，ECMO設備接管心臟的功能，為血液供氧並維持全身循環，讓患者的心臟有時間休息和恢復或修復。這在心臟切開或心臟移植後的心源性休克期間尤其重要，因為心臟可能無法立即維持循環。體外心肺復甦術 (ECPR) 是一種新技術，在心臟麻痹的情況下，特別是當標準復甦努力無法恢復自然循環時，將 ECMO 與傳統 CPR 結合使用。 ECPR 可以快速恢復重要器官的氧血流量，延長成功復甦的時限，並降低因長期缺氧而造成神經病變的風險。在可以快速部署的環境中，ECMO 是一個有價值的選擇，例如心臟中心，時間敏感的干涉措施對患者的生存至關重要。在呼吸系統應用中，ECMO 是一種重要的治療工具，適用於患有嚴重、可逆性呼吸衰竭且對常規治療（包括機械通氣）無反應的患者。急性呼吸窘迫症候群(ARDS)、嚴重肺炎和肺動脈栓塞等疾病可能需要使用 ECMO。 ECMO系統提供充足的氧氣供應並去除二氧化碳，讓肺部休息，同時最大限度地減少人工呼吸器造成的肺損傷。 ECMO 系統在嚴重呼吸道疾病的管理中發揮著至關重要的作用，包括在新型流感和 COVID-19 等感染疾病爆發期間。

最終用戶：專用為醫院加護病房開發先進的ECMO設備

門診手術中心 (ASC) 是提供當天手術治療的醫療機構，包括診斷和預防程序。 ASC 對 ECMO 設備的偏好是基於在複雜手術期間和術後立即為高風險患者提供快速呼吸和心臟支持的需要。這包括預計僅需要短期 ECMO 支援的患者或具有無需長時間住院即可快速解決的特定需求的患者。醫院已成為 ECMO 設備的主要最終用戶，因為它們提供全面且不同級別的患者照護，包括最常使用 ECMO 設備的加護病房。醫院主要使用ECMO機器來治療那些需要長期心臟和呼吸支持的患者，而傳統的機械通氣和藥物治療不足以滿足這些患者的需求。與 ASC 或專科診所相比，醫院通常有更多的基礎設施和資源來管理複雜的 ECMO 病例。專科診所是專門提供特定醫療保健服務的門診設施，也可能提供 ECMO 治療。專科診所可以使用 ECMO 機器為患有複雜但穩定的心臟或呼吸系統疾病且不需要醫院大量資源的患者提供有針對性的支援。 ECMO 設備在這些環境中是首選，因為它們可以進行強化治療，並為有特定需求的患者提供高水準的護理。

區域洞察

由於心血管和呼吸系統疾病的高發病率、完善的醫療基礎設施系統以及熟練專業人員的可用性，體外膜氧合裝置在美洲地區正在經歷顯著成長。此外，由於 COVID-19 大流行，該地區 ECMO 使用量激增，進一步推動了市場擴張。研究和開發資金的增加，加上技術的進步，使 ECMO 系統在重症加護中能力更強、更有效率、更易於使用。歐洲、中東和非洲地區的ECMO設備市場呈現穩定成長。在歐洲，醫療費用上漲、人口老化以及文明病的流行正在影響對 ECMO 的需求。在主要國家，由於先進的醫療體系和有利於醫療設備引進的政策，ECMO的引進正在取得進展。預計亞太地區 ECMO 設備將出現高速成長。經濟開拓、醫療支出增加和人口基數增加是推動市場成長的關鍵力量。主要國家正大力投資升級醫療基礎設施。此外，一些國家的醫療旅遊業正在復甦，為ECMO設備市場開闢了新的途徑。

FPNV定位矩陣

FPNV定位矩陣對於評估體外膜氧合裝置市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對體外膜氧合裝置市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.體外膜氧合裝置市場規模及預測如何？

2.體外膜氧合裝置市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.體外膜氧合裝置市場的技術趨勢和法規結構是什麼？

4.體外膜氧合裝置市場主要廠商的市場佔有率如何？

5.進入體外膜氧合市場的合適型態和策略性手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管和呼吸系統疾病的盛行率
      • 在新生兒護理中引入 ECMO 並擴大 ECMO 中心
    • 抑制因素
      • ECMO 設備的危險召回
    • 機會
      • ECMO設備不斷進步
      • 改善全球 ECMO 設備的報銷方案
    • 任務
      • ECMO 操作和維護相關的潛在複雜性
  • 市場區隔分析
    • 方式：增加使用靜脈-動脈 ECMO 提供心臟和呼吸支持
    • 年齡：呼吸系統疾病和心臟病增加了成人對 ECMO 設備的需求
    • 組件：ECMO 設備對耐用且生物相容性氧氣輸送裝置的需求不斷增加
    • 應用：體外心肺復甦術 (ECPR) 的使用正在迅速增加，因為它可以快速恢復流向重要器官的含氧血流。
    • 最終用戶：開發與醫院加護病房專用相容的先進 ECMO 設備
  • 市場趨勢分析
    • 在美洲建立醫療保健基礎設施並專注於專業研究活動
    • 增加投資以改善亞太地區的醫療保健基礎設施，從而增加 ECMO 設備的部署
    • 加上歐洲、中東和非洲地區 ECMO 計畫和培訓的擴展，評估有效性的研究工作也不斷增加。
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章體外膜氧合裝置市場：依方式分類

  • 動靜脈ECMO
  • 靜脈-動脈ECMO
  • 靜脈ECMO

第7章 體外膜氧合裝置市場依年齡分類

  • 成人用
  • 新生
  • 小兒科

第8章體外膜氧合裝置市場：依組成部分

  • 抗凝血系統
  • 攪拌機
  • 插管
  • 熱交換器
  • 監視系統
  • 氧氣發生器
  • 泵浦

第9章體外膜氧合裝置市場：依應用分類

  • 應用於心
  • 體外心肺復甦
  • 呼吸應用

第10章體外膜氧合裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第11章：北美和南美體外膜氧合裝置市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章：亞太地區體外膜氧合裝置市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章：歐洲、中東和非洲體外膜氧合裝置市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 新南威爾斯州政府 (NSW) 移動心臟治療創新臨床試驗
    • Inspira Technologies在全球最大的體外維生會議上推出INSPIRA ART系列醫療設備
    • AIIMS-R開始ECMO治療
    • 米高梅醫療集團為兒童開設先進的 ECMO 護理設施
    • 雅培生命維持系統獲得 FDA 新批准，幫助醫生治療更多嚴重患者
    • 日本首台ECMO設備發揮重要作用
    • 中國核准銷售自主研發的 ECMO 設備用於治療重症 COVID-19 患者

第15章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-03607F65CC95

[198 Pages Report] The Extracorporeal Membrane Oxygenation Machine Market size was estimated at USD 794.86 million in 2023 and expected to reach USD 832.14 million in 2024, at a CAGR 4.55% to reach USD 1,085.63 million by 2030.

Extracorporeal membrane oxygenation machines are medical devices that provide prolonged cardiac & respiratory support for patients whose hearts and lungs cannot provide adequate gas exchange to sustain life. These machines extract blood from the patient's body, oxygenate it through an artificial lung (the membrane), remove carbon dioxide, and then return it to the patient's bloodstream. This external life support system takes over the function of the heart and lungs, allowing these organs to rest and heal during critical illness. The surging prevalence of cardiovascular and respiratory diseases and technological advancements that improve patient outcomes have increased the adoption of ECMO systems. Additionally, improvements in healthcare infrastructure and increased healthcare spending are contributing to the market expansion. High costs associated with ECMO procedures and a limited number of trained healthcare professionals to operate these machines represent a challenge for market growth. Nevertheless, advancements in ECMO machine design to enhance portability and ease of use in different treatment settings are expected to provide opportunistic scope for the market. Moreover, ECMO integration with other extracorporeal therapies and research activities focused on expanding the indications for ECMO support is expected to boost the market.

KEY MARKET STATISTICS
Base Year [2023] USD 794.86 million
Estimated Year [2024] USD 832.14 million
Forecast Year [2030] USD 1,085.63 million
CAGR (%) 4.55%

Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support

Arteriovenous extracorporeal membrane oxygenation (AV ECMO) is an older method of ECMO support that utilizes the patient's arterial and venous blood flow to drive blood through the ECMO circuit. In AV ECMO, blood is drawn from an artery and returned to a vein after oxygenation. This technique relies on the patient's heart to pump blood through the oxygenator. It is less commonly used in modern ECMO therapy due to advancements in technology that prefer other modes for efficiency and safety. Venoarterial extracorporeal membrane oxygenation (VA ECMO) provides both cardiac and respiratory support by withdrawing venous blood, which is then oxygenated outside of the body and infused back into an artery. VA ECMO is used in cases of severe heart failure or cardiac arrest because it bypasses both the heart and the lungs, thus providing full support to these organs. The cannulation is usually done through the large central vessels, such as the femoral or carotid artery and vein. VA ECMO is utilized primarily for respiratory support, where blood is removed from a large vein, oxygenated through the ECMO circuit, and returned to a vein. This mode of ECMO ensures adequate oxygenation when the lungs are severely compromised by conditions including acute respiratory distress syndrome (ARDS) or pneumonia. The typical cannulation sites for VV ECMO include the internal jugular and femoral veins.

Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders

Adult patients who require ECMO therapy suffer from severe respiratory or cardiac conditions that are unresponsive to conventional management. These include conditions such as acute respiratory distress syndrome (ARDS), cardiogenic shock, or pulmonary embolism. Adult ECMO machines are designed to manage larger blood flow with durable components that can withstand extended use. Neonates require ECMO support due to conditions present at birth, such as congenital diaphragmatic hernia or meconium aspiration syndrome. Neonatal ECMO machines are designed to handle the delicate and minimal blood volume of newborns with precise control and gentle flow to minimize the risk of hemolysis or other blood-related complications. The primary distinction for neonatal ECMO machines is the focus on reducing invasiveness and limiting the extracorporeal circuit volume to suit the patient's size. The machines also have smaller cannulae and specialized circuits than those used for older children and adults. Pediatric patients, ranging from infants to older children, may require ECMO due to various respiratory and cardiac failures that are unresponsive to standard treatment. Pediatric ECMO machines must be versatile to accommodate the wide age and size range of patients in this group, with adjustability in flow rates and oxygenator sizes.

Component: Increasing need for durable and biocompatible oxygenators for ECMO machines

Anticoagulation systems are integral to the ECMO setup, preventing blood from clotting as it travels outside the body through the ECMO circuit. Blenders in ECMO machines mix air with pure oxygen, delivering controlled oxygen levels to the patient. Blenders must offer adjustable oxygen concentration ranges to cater to varying patient needs. Cannulae are conduits for blood flow between the patient and the ECMO machine, which come in various sizes and materials tailored to specific patient anatomy and surgical requirements. Heat exchangers regulate the blood temperature during ECMO therapy, crucial for maintaining the patient's core temperature. Monitoring systems are critical for overseeing the patient's vitals and the ECMO machine's performance. The oxygenator is the heart of the ECMO machine, where gas exchange occurs. Manufacturers are currently producing oxygenators that maximize gas exchange efficiency while minimizing blood trauma. The pump propels blood through the ECMO circuit, and centrifugal and roller pumps are the two primary pumps in ECMO machines. Centrifugal pumps are preferred for their lower hemolysis rates, while roller pumps are favored for their simplicity and cost-effectiveness.

Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs

ECMO machines are widely used in cardiac applications as a life-supporting bridge for patients experiencing severe heart failure or during high-risk cardiac procedures. When used this way, the ECMO machine takes over the heart's function to oxygenate the blood and sustain systemic circulation, giving the patient's heart time to rest and recover or be repaired. This is particularly crucial during postcardiotomy cardiogenic shock or cardiac transplantation when the heart may not immediately sustain circulation. Extracorporeal Cardiopulmonary Resuscitation (ECPR) is an emerging technique where ECMO is employed alongside conventional CPR in cases of cardiac arrest, especially when the standard resuscitation efforts do not lead to a return of spontaneous circulation. ECPR can quickly restore oxygenated blood flow to vital organs, thus extending the timeframe for successful resuscitation and reducing the risk of neurological damage due to prolonged oxygen deprivation. It represents a valuable option in environments that facilitate rapid deployment, such as in specialized cardiac centers where time-sensitive interventions can be critical to patient survival. In respiratory applications, ECMO is a pivotal treatment modality for patients experiencing severe and potentially reversible respiratory failure that is not responsive to conventional management, including mechanical ventilation. Conditions including acute respiratory distress syndrome (ARDS), severe pneumonia, or pulmonary embolism may warrant the use of ECMO. The ECMO system allows the lungs to rest while minimizing ventilator-induced lung injury by providing adequate oxygenation and removing carbon dioxide. The ECMO system has played a pivotal role in managing critical respiratory conditions, including during outbreaks of infectious diseases such as the H1N1 influenza and COVID-19.

End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals

Ambulatory surgical centers (ASCs) are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. The preference for ECMO machines in ASCs is based on the need to provide prompt respiratory or cardiac support for high-risk patients during complex surgeries or in the immediate postoperative period. This includes patients anticipated to require only a brief duration of ECMO support or those with specific needs that can be addressed rapidly without an extended hospital stay. Hospitals serve as the primary end-user segment for ECMO machines due to the comprehensive and varied levels of patient care they provide, including intensive care units where ECMO machines are most commonly utilized. Hospitals mainly use ECMO machines for patients requiring extended cardiac and respiratory support that cannot be adequately delivered through conventional ventilation or medication. Hospitals generally have greater infrastructure and resources to manage complex ECMO cases than ASCs or specialty clinics. Specialty clinics are outpatient facilities that focus on specific healthcare services, which may include providing ECMO treatment. Specialty clinics may employ ECMO machines to provide targeted support for patients with complex but stable cardiac or respiratory conditions that do not require the extensive resources of a hospital setting. The preference for ECMO machines in this setting is for a focused approach to treatment, offering advanced care to patients with specific needs.

Regional Insights

In the Americas region, extracorporeal membrane oxygenation machines have seen significant growth driven by the high incidence rates of cardiovascular and respiratory diseases, a well-established healthcare infrastructure system, and the availability of skilled professionals. Additionally, the region has seen a surge in ECMO utilization due to the COVID-19 pandemic, further fueling market expansion. Increased funding for research and development, coupled with technological advancements, continues to enhance ECMO system capabilities, making them more efficient and user-friendly for critical care adoption. The market landscape for ECMO machines in the EMEA region exhibits steady growth. In Europe, the demand for ECMO support is influenced by rising healthcare expenditures, an aging population, and the prevalence of lifestyle-associated diseases. Major economies are implementing ECMOs due to their advanced healthcare systems and policies that favor adopting medical devices. The Asia-Pacific region shows high-growth prospects for ECMO machines. Economic development, increasing healthcare expenditure, and a growing population base are pivotal forces propelling market growth. Major economies are investing heavily in upgrading their healthcare infrastructure. Moreover, the boosting medical tourism industry in some economies is also opening new avenues for the ECMO machines market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Extracorporeal Membrane Oxygenation Machine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Extracorporeal Membrane Oxygenation Machine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal Membrane Oxygenation Machine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corporation, Dragerwerk AG & Co. KGaA, Eurosets S.R.L., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hengko Technology Co., Ltd., Inspira Technologies OXY B.H.N. Ltd., LivaNova PLC, MC3 Cardiopulmonary, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shenzhen Mindray Biomedical Electronics Co. Ltd., Technimount System, Terumo Corporation, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal Membrane Oxygenation Machine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Modality
    • Arteriovenous ECMO
    • Venoarterial ECMO
    • Venovenous ECMO
  • Age
    • Adult
    • Neonate
    • Pediatric
  • Component
    • Anticoagulation Systems
    • Blender
    • Cannulae
    • Heat Exchanger
    • Monitoring Systems
    • Oxygenator
    • Pump
  • Application
    • Cardiac Application
    • Extracorporeal Cardiopulmonary Resuscitation
    • Respiratory Application
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Extracorporeal Membrane Oxygenation Machine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Extracorporeal Membrane Oxygenation Machine Market?

3. What are the technology trends and regulatory frameworks in the Extracorporeal Membrane Oxygenation Machine Market?

4. What is the market share of the leading vendors in the Extracorporeal Membrane Oxygenation Machine Market?

5. Which modes and strategic moves are suitable for entering the Extracorporeal Membrane Oxygenation Machine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiovascular and respiratory diseases
      • 5.1.1.2. Adoption of ECMO for neonatal care and expansion of ECMO centers
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of ECMO machines
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in ECMO machines
      • 5.1.3.2. Improving reimbursement scenario for ECMO machines worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Potential complexity associated with the operation and maintenance of ECMO
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support
    • 5.2.2. Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders
    • 5.2.3. Component: Increasing need for durable and biocompatible oxygenators for ECMO machines
    • 5.2.4. Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs
    • 5.2.5. End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals
  • 5.3. Market Trend Analysis
    • 5.3.1. Established healthcare infrastructure and focused on specialized research efforts across the Americas
    • 5.3.2. Increasing deployment of ECMO machines with rising investment for improving healthcare infrastructure across the APAC region
    • 5.3.3. Increasing research activities for evaluating effectiveness, coupled with growing ECMO programs and training in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Extracorporeal Membrane Oxygenation Machine Market, by Modality

  • 6.1. Introduction
  • 6.2. Arteriovenous ECMO
  • 6.3. Venoarterial ECMO
  • 6.4. Venovenous ECMO

7. Extracorporeal Membrane Oxygenation Machine Market, by Age

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Neonate
  • 7.4. Pediatric

8. Extracorporeal Membrane Oxygenation Machine Market, by Component

  • 8.1. Introduction
  • 8.2. Anticoagulation Systems
  • 8.3. Blender
  • 8.4. Cannulae
  • 8.5. Heat Exchanger
  • 8.6. Monitoring Systems
  • 8.7. Oxygenator
  • 8.8. Pump

9. Extracorporeal Membrane Oxygenation Machine Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiac Application
  • 9.3. Extracorporeal Cardiopulmonary Resuscitation
  • 9.4. Respiratory Application

10. Extracorporeal Membrane Oxygenation Machine Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Americas Extracorporeal Membrane Oxygenation Machine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. The Government of New South Wales (NSW)'s New Innovative Clinical Trial with Mobile Cardiac Treatment
    • 14.3.2. Inspira Technologies Unveils the INSPIRA ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
    • 14.3.3. AIIMS-R Starts ECMO Treatment
    • 14.3.4. MGM Healthcare Inaugurates Advanced ECMO Care Facility for Children
    • 14.3.5. Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
    • 14.3.6. First Domestic ECMO Machine to Play Vital Role
    • 14.3.7. China Grants Market Approval to Self-Developed ECMO Device for Severe COVID-19 Cases

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET RESEARCH PROCESS
  • FIGURE 2. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ARTERIOVENOUS ECMO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ARTERIOVENOUS ECMO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY NEONATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY NEONATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ANTICOAGULATION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ANTICOAGULATION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY BLENDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY BLENDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULAE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULAE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC APPLICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC APPLICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY APPLICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY APPLICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SI